ACM
EVO icon

ADAR1 Capital Management’s Evotec EVO Stock Holding History

ADAR1 Capital Management’s Portfolio EVO Stock Details EVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,400
Closed -$45.1K – 301
2024
Q2 		$45.1K Buy
9,400
+1,700
+22% +$9.53K 0.01% 192
2024
Q1 		$60.3K Buy
+7,700
New +$60.6K 0.01% 172

Other funds holding EVO

MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $375M AUM 72.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CHAM
Clear Harbor Asset Management Stamford, Connecticut $1.45B AUM 23.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ADAR1 Capital Management's EVO Position: Q3 2024 in Review

ADAR1 Capital Management sold out of Evotec (EVO) in Q3 2024, closing a stake of 9,400 shares — an estimated $45.1K sold.

ADAR1 Capital Management first reported a position in EVO in Q1 2024 and held it in 2 quarters. The position peaked at $60.3K in Q1 2024. 24 funds tracked by Wall St. Rank hold EVO as of Q3 2024.

  • ADAR1 Capital Management reported no remaining Evotec position as of Q3 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 9,400 Evotec shares in Q3 2024, an estimated $45.1K.
  • ADAR1 Capital Management first reported a position in Evotec in Q1 2024 and held it in 2 quarters.
  • ADAR1 Capital Management's Evotec position peaked at $60.3K in Q1 2024.
  • 24 funds tracked by Wall St. Rank held Evotec as of Q3 2024.

Based on ADAR1 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.